Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment

Novartis
Business & Industry News Channel
Novartis
Sanofi
CureVac
Pfizer
Moderna, Inc.
Novartis
Sanofi
Sanofi will leverage its established infrastructure and manufacturing expertise at its site in Ridgefield, NJ, to perform fill and finish of up to 200 million doses of Moderna's COVID-19 vaccine, starting in September 2021.